SRC-01
European Commission
Article 4 consultation โ nicotinamide mononucleotide
Novel Food conclusion for NMN at 95โ99% purity produced enzymatically
RULE / SOURCE VERSIONPublished 11 October 2022Open primary source โ
EU + POLAND EVIDENCE PROFILE
NMN supplement compliance
A defined molecule with a published EU Novel Food conclusion and active application history โ not a shortcut to market access.
STATUSNOVEL FOOD SIGNAL
JURISDICTIONEuropean Union ยท Poland
RULE VERSIONSV-ING-NMN-2026.09
LAST CHECKED2026-09-12
SOURCE FRESHNESSPOINT-IN-TIME SOURCE CHECKNO LIVE MONITORING
LAST VERIFIED2026-09-12SV-ING-NMN-2026.09
PRIMARY AUTHORITY REFERENCEEuropean Commission ยท Article 4 consultation โ nicotinamide mononucleotidePublished 11 October 2022 โTRANSLATION BOUNDARYORIGINAL AUTHORITY TEXT CONTROLSPage summaries and working translations are context, not decision sources.
This profile records the cited evidence at the stated date. Re-check the authority source before a final formula, claim, artwork or market-access decision.
01
IDENTITY BEFORE STATUS
Name, part and form
- Name
- NMN
- Synonyms
- ฮฒ-NMN ยท beta-nicotinamide mononucleotide ยท nicotinamide mononucleotide
- Botanical / chemical identity
- Not applicable โ defined chemical substance.
- Plant part
- Not applicable.
- Reviewed form
- Nicotinamide mononucleotide at 95โ99% purity produced by enzymatic technology; other processes need comparison.
02
CLAIMS
What the profile supports
NO AUTHORISED CLAIM ASSERTED
- Longevity, anti-ageing, NAD+, energy and metabolic wording all need separate claims and misleading-presentation review.
- Safety material in an application dossier is not an authorised health claim.
A Novel Food application is not an authorisation. Confirm the current Union list before any market-access conclusion.
03
RESTRICTIONS
Conditions that can change the answer
- 01
Treat the cited 95โ99% NMN as Novel Food unless a matching Union-list authorisation and conditions are evidenced.
- 02
Match identity, purity, production process, intended use, daily intake and target population to any relied-on authorisation.
- 03
Do not present a pending or published application summary as permission to sell.
04
POLISH NOTES
National regulatory layer
EU Novel Food authorisation is a gate before a Polish supplement notification can resolve product placement.
Keep anti-ageing and disease-adjacent presentation out of the ingredient identity analysis; review it separately as marketing content.
05
PRIMARY SOURCES
Evidence ledger
SRC-02
European Commission
Summary of Novel Food applications
Application history; not evidence of authorisation
RULE / SOURCE VERSIONLive applications index, checked 12 September 2026Open primary source โ
SRC-03
European Commission
Union list of authorised novel foods
Market-authorisation verification gate
RULE / SOURCE VERSIONRegulation (EU) 2017/2470, live update index checked 12 September 2026Open primary source โ
PRODUCT-LEVEL CHECK
Check your product โ